Cited by 675Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Multiple Functions of Endocannabinoid Signaling in the Brain

Open access

Katona, István, Freund, Tamás F.·2012·Annual Review of Neuroscience

DOI 10.1146/annurev-neuro-062111-150420PMC PMC4273654

Open this paper in CoChat — free account

Abstract

Despite being regarded as a hippie science for decades, cannabinoid research has finally found its well-deserved position in mainstream neuroscience. A series of groundbreaking discoveries revealed that endocannabinoid molecules are as widespread and important as conventional neurotransmitters such as glutamate or GABA, yet they act in profoundly unconventional ways. We aim to illustrate how uncovering the molecular, anatomical, and physiological characteristics of endocannabinoid signaling has revealed new mechanistic insights into several fundamental phenomena in synaptic physiology. First, we summarize unexpected advances in the molecular complexity of biogenesis and inactivation of the two endocannabinoids, anandamide and 2-arachidonoylglycerol. Then, we show how these new metabolic routes are integrated into well-known intracellular signaling pathways. These endocannabinoid-producing signalosomes operate in phasic and tonic modes, thereby differentially governing homeostatic, short-term, and long-term synaptic plasticity throughout the brain. Finally, we discuss how cell type– and synapse-specific refinement of endocannabinoid signaling may explain the characteristic behavioral effects of cannabinoids.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-neuro-062111-150420

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,182
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“1C-D) (Devane et al., 1988; Bidaut-Russell et al., 1990).”
Background
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125

Show all 183 references

Research works printed but not linked: 1

Gaoni Y, 1967, Tetrahedron Lett., 12, 1109

Sorted by citations

Items 101–200 of 675

Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats
Morena, M., Nastase, A. S., Santori, A., Cravatt, B. F., Shansky, R. M., & Hill, M. N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15341 · Cited by 72
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
Lee, T. T.-Y., Hill, M. N., & Lee, F. S. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12253 · Cited by 71
Intracellular GPCRs Play Key Roles in Synaptic Plasticity
Jong, Y.-J. I., Harmon, S. K., & O’Malley, K. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00516 · Cited by 71
Mechanisms of endocannabinoid control of synaptic plasticity
Winters, B. L., & Vaughan, C. W. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108736 · Cited by 70
Amplification of mGlu5-Endocannabinoid Signaling Rescues Behavioral and Synaptic Deficits in a Mouse Model of Adolescent and Adult Dietary Polyunsaturated Fatty Acid Imbalance
Manduca, A., Bara, A., Larrieu, T., Lassalle, O., Joffre, C., Layé, S., & Manzoni, O. J. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3516-16.2017 · Cited by 69
Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety
Morena, M., Aukema, R. J., Leitl, K. D., Rashid, A. J., Vecchiarelli, H. A., Josselyn, S. A., & Hill, M. N. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-18.2018 · Cited by 68
Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder
Crombie, K. M., Brellenthin, A. G., Hillard, C. J., & Koltyn, K. F. (2018) · Journal of Traumatic Stress · doi:10.1002/jts.22253 · Cited by 68
The neuropharmacology of cannabinoid receptor ligands in central signaling pathways
Brunt, T. M., & Bossong, M. G. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14982 · Cited by 67
Endocannabinoid system and pain: an introduction
Burston, J. J., & Woodhams, S. G. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003650 · Cited by 67
Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in Neurons
Baggelaar, M. P., Chameau, P. J. P., Kantae, V., Hummel, J. J. A., Hsu, K., Janssen, F. J., van der Wel, T., Soethoudt, M., Deng, H., den Dulk, H., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b04883 · Cited by 67
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke
Bravo‐Ferrer, I., Cuartero, M. I., Zarruk, J. G., Pradillo, J. M., Hurtado, O., Romera, V. G., Díaz-Alonso, J., García-Segura, J. M., Guzmán, M., Lizasoaín, I., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.014793 · Cited by 65
Early life stress alters the developmental trajectory of corticolimbic endocannabinoid signaling in male rats
Hill, M. N., Eiland, L. R., Lee, T. T.-Y., Hillard, C. J., & McEwen, B. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.036 · Cited by 65
Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala
Yasmin, F., Colangeli, R., Morena, M., Filipski, S. B., van der Stelt, M., Pittman, Q. J., Hillard, C. J., Teskey, G. C., McEwen, B. S., Hill, M. N., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910322116 · Cited by 65
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Singewald, N., Sartori, S. B., Reif, A., & Holmes, A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109418 · Cited by 64
Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research
Sagar, K. A., & Gruber, S. A. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1460334 · Cited by 64
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats
Zhou, H., Zhang, Z., Wei, H., Wang, F., Guo, F., Gao, Z., Marsicano, G., Wang, Q., & Xiong, L. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.006 · Cited by 63
Effects of cannabis tetrahydrocannabinol on endocannabinoid homeostasis in human placenta
Maia, J. C., Midão, L., Cunha, S. C., Almada, M., Fonseca, B. M., Braga, J. S., Gonçalves, D. R., Teixeira, N. A. A., & Correia‐da‐Silva, G. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02389-7 · Cited by 63
The Cannabidiol Use in the Treatment of Epilepsy
Matos, R. L. A., Spinola, L. A., Barboza, L. L., Garcia, D. R., França, T. C. C., & Affonso, R. S. (2017) · Revista Virtual de Química · doi:10.21577/1984-6835.20170049 · Cited by 62
Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)
Bossong, M. G., Jansma, J. M., Bhattacharyya, S., & Ramsey, N. F. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 62
Acute inhibition of diacylglycerol lipase blocks endocannabinoid‐mediated retrograde signalling: evidence for on‐demand biosynthesis of 2‐arachidonoylglycerol
Hashimotodani, Y., Ohno‐Shosaku, T., Tanimura, A., Kita, Y., Sano, Y., Shimizu, T., Marzo, V. D., & Kano, M. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.254474 · Cited by 62
Endocannabinoid metabolism by cytochrome P450 monooxygenases
Zelasko, S. E., Arnold, W. R., & Das, A. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.11.002 · Cited by 61
Cannabis and cannabinoids: pharmacology and therapeutic potential
Śmiarowska, M., Białecka, M., & Machoy-Mokrzyńska, A. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0015 · Cited by 60
A cortico-amygdala neural substrate for endocannabinoid modulation of fear extinction
Gunduz‐Cinar, O., Castillo, L. I., Xia, M. Y., Leer, E. V., Brockway, E. T., Pollack, G. A., Yasmin, F., Bukalo, O., Limoges, A., Oreizi-Esfahani, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.06.023 · Cited by 64
Mechanisms of endocannabinoid transport in the brain
Kaczocha, M., & Haj‐Dahmane, S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15469 · Cited by 60
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
Xiong, Y., & Lim, C. (2021) · Brain Sciences · doi:10.3390/brainsci11091211 · Cited by 60
Exercise-induced increases in Anandamide and BDNF during extinction consolidation contribute to reduced threat following reinstatement: Preliminary evidence from a randomized controlled trial
Crombie, K. M., Sartin‐Tarm, A., Sellnow, K. A., Ahrenholtz, R., Lee, S., Matalamaki, M., Almassi, N. E., Hillard, C. J., Koltyn, K. F., Adams, T. G., et al. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105355 · Cited by 59
Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood–brain barrier alterations
Dudek, K., Paton, S. E. J., Binder, L. B., Collignon, A., Dion‐Albert, L., Cadoret, A., Lebel, M., Lavoie, O., Bouchard, J., Kaufmann, F. N., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01891-9 · Cited by 59
Presynaptic adenosine A 2A receptors dampen cannabinoid CB 1 receptor‐mediated inhibition of corticostriatal glutamatergic transmission
Ferreira, S. G., Gonçalves, F. Q., Marques, J. M., Tomé, Â. R., Rodrigues, R. J., Nunes‐Correia, I., Ledent, C. A., Harkany, T., Venance, L., Cunha, R. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12970 · Cited by 59
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
Scherma, M., Muntoni, A. L., Melis, M., Fattore, L., Fadda, P., Fratta, W., & Pistis, M. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4196-3 · Cited by 59
The role of fatty acids and their endocannabinoid-like derivatives in the molecular regulation of appetite
Witkamp, R. F. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.002 · Cited by 59
Determination of endocannabinoids and N-acylethanolamines in human hair with LC-MS/MS and their relation to symptoms of depression, burnout, and anxiety
Gao, W., Walther, A., Wekenborg, M., Penz, M. S., & Kirschbaum, C. (2020) · Talanta · doi:10.1016/j.talanta.2020.121006 · Cited by 58
Invertebrate Models in Addiction Research
Søvik, E., & Barron, A. B. (2013) · Brain Behavior and Evolution · doi:10.1159/000355506 · Cited by 57
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity
Colangeli, R., Pierucci, M., Benigno, A., Campiani, G., Butini, S., & Giovanni, G. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-11606-1 · Cited by 56
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease
Köfalvi, A., Lemos, C., Martín-Moreno, A. M., Pinheiro, B. S., García‐García, L., Pozo, M. A., Valério-Fernandes, Â., Beleza, R. O., Agostinho, P. M., Rodrigues, R. J., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.015 · Cited by 55
Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events
Davidson, C., Opacka‐Juffry, J., Arévalo‐Martín, Á., García‐Ovejero, D., Molina‐Holgado, E., & Molina‐Holgado, F. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.001 · Cited by 55
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Senn, L., Cannazza, G., & Biagini, G. (2020) · Pharmaceuticals · doi:10.3390/ph13080174 · Cited by 55
Integrating endocannabinoid signaling in the regulation of anxiety and depression
Yin, A., Wang, F., & Zhang, X. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0051-5 · Cited by 54
Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
Fletcher-Jones, A., Hildick, K. L., Evans, A. J., Nakamura, Y., Henley, J. M., & Wilkinson, K. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00108 · Cited by 54
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling
Su, S., Wang, Y.-Q., Wu, Y., Wang, D., Lin, Q. D., & Hai, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.009 · Cited by 53
A single session of moderate intensity exercise influences memory, endocannabinoids and brain derived neurotrophic factor levels in men
Bosch, B. M., Bringard, A., Logrieco, M. G., Lauer, E., Imobersteg, N., Thomas, A., Ferretti, G., Schwartz, S., & Iglói, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-93813-5 · Cited by 53
Microglia NLRP3 Inflammasome and Neuroimmune Signaling in Substance Use Disorders
Guo, M., Roodsari, S. K., Cheng, Y., Dempsey, R. E., & Hu, W. (2023) · Biomolecules · doi:10.3390/biom13060922 · Cited by 52
Endogenous cannabinoid signaling at inhibitory interneurons
Younts, T. J., & Castillo, P. E. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.12.006 · Cited by 52
Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
Rivera, P., Bîndilă, L., Pastor, A., Pérez‐Martín, M., Pavón, F. J., Serrano, A., de la Torre, R., Lutz, B., de Fonseca, F. R., & Suárez, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00098 · Cited by 51
Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis
Worley, N. B., Hill, M. N., & Christianson, J. P. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.004 · Cited by 51
Endocannabinoid signaling in hypothalamic circuits regulates arousal from general anesthesia in mice
Zhong, H., Li, T., Gu, N., Gao, F., Lu, Y.-C., Xie, R., Liu, J., Li, X., Bergeron, R., Pomeranz, L. E., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91038 · Cited by 51
Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis
Rodrigues, R. S., Ribeiro, F. F., Ferreira, F., Vaz, S. H., Sebastião, A. M., & Xapelli, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00516 · Cited by 51
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways
Gómez, O., Sanchez-Rodriguez, M. A., Ortega‐Gutiérrez, S., Vázquez‐Villa, H., Guaza, C., Molina‐Holgado, F., & Molina‐Holgado, E. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9609-x · Cited by 50
Insular cortex corticotropin-releasing factor integrates stress signaling with social affective behavior
Rieger, N. S., Varela, J. A., Ng, A. J., Granata, L. E., Djerdjaj, A., Brenhouse, H. C., & Christianson, J. P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01292-7 · Cited by 50
Endocannabinoid‐dependent plasticity at spinal nociceptor synapses
Kato, A., Punnakkal, P., Pernía‐Andrade, A. J., von Schoultz, C., Sharopov, S., Nyilas, R., Katona, I., & Zeilhofer, H. U. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.234229 · Cited by 50
Self-citation
Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00623 · Cited by 49
The Ratio of 2-AG to Its Isomer 1-AG as an Intrinsic Fine Tuning Mechanism of CB1 Receptor Activation
Dócs, K., Mészár, Z., Gonda, S., Kiss‐Szikszai, A., Holló, K., Antal, M., & Hegyi, Z. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00039 · Cited by 49
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
Leweke, F. M., Mueller, J. K., Lange, B., Fritze, S., Topor, C. E., Koethe, D., & Rohleder, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0539-z · Cited by 48
Lights on Endocannabinoid-Mediated Synaptic Potentiation
Piette, C., Cui, Y., Gervasi, N., & Venance, L. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00132 · Cited by 48
The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
Coelho, M., Duarte, P., Calado, M. S., Almeida, A. J., Reis, C. P., & Gaspar, M. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121838 · Cited by 47
Cerebellar alterations in cannabis users: A systematic review
Blithikioti, C., Miquel, L., Batalla, A., Ballester, B. R., Maffei, G., Herreros, I., Gual, A., Verschure, P. F. M. J., & Balcells‐Oliveró, M. (2019) · Addiction Biology · doi:10.1111/adb.12714 · Cited by 47
Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear
Ivy, D. M., Palese, F., Vozella, V., Fotio, Y., Yalcin, A., Ramirez, G. L., Mears, D. J., Wynn, G. H., & Piomelli, D. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0696-x · Cited by 47
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Navarro, D., Gasparyan, A., Navarrete, F., Torregrosa, A. B., Rubio, G., Marín, M., Acosta, G. B., García‐Gutiérrez, M. S., & Manzanares, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094764 · Cited by 47
Endocannabinoid system: Potential novel targets for treatment of schizophrenia
Saito, A., Ballinger, M. D., Pletnikov, M. V., Wong, D. F., & Kamiya, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.020 · Cited by 47
Anatomical characterization of the cannabinoid CB1 receptor in cell‐type–specific mutant mouse rescue models
Gutiérrez‐Rodríguez, A., Puente, N., Elezgarai, I., Ruehle, S., Lutz, B., Reguero, L., Gerrikagoitia, I., Marsicano, G., & Grandes, P. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24066 · Cited by 46
The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy
Slusar, J. E., Cairns, E. A., Szczesniak, A.-M., Bradshaw, H. B., Polo, A. D., & Kelly, M. E. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.018 · Cited by 46
The Endocannabinoid System, Aggression, and the Violence of Synthetic Cannabinoid Use, Borderline Personality Disorder, Antisocial Personality Disorder, and Other Psychiatric Disorders
Kolla, N. J., & Mishra, A. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00041 · Cited by 46
Aerobic exercise reduces anxiety and fear ratings to threat and increases circulating endocannabinoids in women with and without PTSD
Crombie, K. M., Cisler, J. M., Hillard, C. J., & Koltyn, K. F. (2020) · Mental health and physical activity · doi:10.1016/j.mhpa.2020.100366 · Cited by 46
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals
Lenkey, N., Kirizs, T., Holderith, N., Máté, Z., Szabó, G., Vizi, E. S., Hájos, N., & Nusser, Z. (2015) · Nature Communications · doi:10.1038/ncomms7557 · Cited by 45
Glial Control of Endocannabinoid Heterosynaptic Modulation in Hypothalamic Magnocellular Neuroendocrine Cells
Di, S., Popescu, I., & Tasker, J. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2971-12.2013 · Cited by 45
Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus
Guggenhuber, S., Alpár, A., Chen, R., Schmitz, N., Wickert, M., Mattheus, T., Harasta, A. E., Purrio, M., Kaiser, N., Elphick, M. R., et al. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1027-6 · Cited by 45
The acute effects of cannabis on human executive function
Oomen, P. P., van Hell, H. H., & Bossong, M. G. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000426 · Cited by 45
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons
Remmers, F., Lange, M. D., Hamann, M., Ruehle, S., Pape, H., & Lutz, B. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1411-5 · Cited by 44
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence
Rodrigues, R. J., Marques, J. M., & Köfalvi, A. (2024) · Cells · doi:10.3390/cells13221875 · Cited by 43
Antibodies to cannabinoid type 1 receptor co‐react with stomatin‐like protein 2 in mouse brain mitochondria
Morozov, Y. M., Dominguez, M. H., Varela, L., Shanabrough, M., Koch, M., Horváth, T. L., & RAKIC, P. T. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12237 · Cited by 43
Changing the tune: plasticity and adaptation of retrograde signals
Iremonger, K. J., Cusulin, J. I. W., & Bains, J. S. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.007 · Cited by 43
Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Suryadevara, U., Bruijnzeel, D. M., Nuthi, M., Jagnarine, D. A., Tandon, R., & Bruijnzeel, A. W. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161101095325 · Cited by 43
Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder – a pilot study
Wingenfeld, K., Dettenborn, L., Kirschbaum, C., Gao, W., Otte, C., & Roepke, S. (2018) · Stress · doi:10.1080/10253890.2018.1451837 · Cited by 43
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
Scherma, M., Masia, P., Deidda, M. L., Fratta, W., Tanda, G., & Fadda, P. (2018) · Medicines · doi:10.3390/medicines5040107 · Cited by 43
Aerobic exercise in the treatment of PTSD: An examination of preclinical and clinical laboratory findings, potential mechanisms, clinical implications, and future directions
Crombie, K. M., Adams, T. G., Dunsmoor, J. E., Greenwood, B. N., Smits, J. A. J., Nemeroff, C. B., & Cisler, J. M. (2023) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2023.102680 · Cited by 42
Specific Hippocampal Interneurons Shape Consolidation of Recognition Memory
da Cruz, J. F. O., Busquets-García, A., Zhao, Z., Varilh, M., Lavanco, G., Bellocchio, L., Robin, L. M., Cannich, A., Julio‐Kalajzić, F., Lesté-Lasserre, T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2020.108046 · Cited by 42
Endocannabinoid signaling in the lateral habenula regulates pain and alcohol consumption
Fu, R., Tang, Y. M., Li, W., Ren, Z., Li, D., Zheng, J., Zuo, W., Chen, X., Zuo, Q., Tam, K. L., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01337-3 · Cited by 42
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory
Ballinger, M. D., Saito, A., Abazyan, B. N., Taniguchi, Y., Huang, C.-H., Ito, K., Zhu, X., Segal‐Gavish, H., Jaaro-Peled, H., Sawa, A., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.006 · Cited by 42
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex
Martin, H. G. S., Bernabeu, A., Lassalle, O., Bouille, C., Beurrier, C., Pélissier‐Alicot, A., & Manzoni, O. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00457 · Cited by 41
Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling
Franks, A. L., Berry, K. J., & DeFranco, D. B. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12786 · Cited by 41
Receptor-Dependent and Independent Regulation of Voltage-Gated Ca2+ Channels and Ca2+-Permeable Channels by Endocannabinoids in the Brain
Boczek, T., & Żylińska, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158168 · Cited by 41
Receptor Trafficking and the Regulation of Synaptic Plasticity by SUMO
Luo, J., Ashikaga, E., Rubin, P. P., Heimann, M. J., Hildick, K. L., Bishop, P., Girach, F., Josa‐Prado, F., Tang, L. T. H., Carmichael, R. E., et al. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8253-y · Cited by 40
Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses
Zhao, L., Yeh, M. L., & Levine, E. S. (2015) · eNeuro · doi:10.1523/eneuro.0029-14.2015 · Cited by 40
Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex
Chou, S., Ranganath, T., Fish, K. N., Lewis, D. A., & Sweet, R. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-13724-x · Cited by 39
Sex-dimorphism in human serum endocannabinoid and n-acyl ethanolamine concentrations across the lifespan
Hamzah, K. A., Toms, L.-M. L., Kucharski, N., Orr, J. S., Turner, N. P., Hobson, P., Nichols, D. S., & Ney, L. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-50426-4 · Cited by 39
Endocannabinoid long-term depression revealed at medial perforant path excitatory synapses in the dentate gyrus
Peñasco, S., Rico‐Barrio, I., Puente, N., Gómez‐Urquijo, S., Fontaine, C. J., Huguet, J. E., Achicallende, S., Ramos, A., Reguero, L., Elezgarai, I., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.020 · Cited by 39
Transient Receptor Potential Vanilloid 1 Function at Central Synapses in Health and Disease
Meza, R. C., Ancatén-González, C., Chiu, C. Q., & Chávez, A. E. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.864828 · Cited by 39
Activation of type-1 cannabinoid receptor shifts the balance between excitation and inhibition towards excitation in layer II/III pyramidal neurons of the rat prelimbic cortex
den Boon, F. S., Werkman, T. R., Schaafsma-Zhao, Q., Houthuijs, K. J., Vitalis, T., Kruse, C. G., Wadman, W. J., & Chameau, P. J. P. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1586-z · Cited by 39
Radiosynthesis and ex vivo evaluation of [11C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors
Hicks, J. W., Parkes, J., Tong, J., Houle, S., Vasdev, N., & Wilson, A. A. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.05.001 · Cited by 39
Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping
Ferber, S. G., Trezza, V., & Weller, A. (2019) · Developmental Psychobiology · doi:10.1002/dev.21944 · Cited by 38
Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior
Bilbao, A., Neuhofer, D., Sepers, M. D., Wei, S., Eisenhardt, M., Hertle, S., Lassalle, O., Ramos, A., Puente, N., Lerner, R., et al. (2020) · iScience · doi:10.1016/j.isci.2020.100951 · Cited by 39
Omega-6 and omega-3 fatty acids: Endocannabinoids, genetics and obesity
Simopoulos, A. P. (2020) · OCL · doi:10.1051/ocl/2019046 · Cited by 38
Synaptic changes induced by cannabinoid drugs and cannabis use disorder
Augustin, S. M., & Lovinger, D. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105670 · Cited by 38
Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges
Costa, A. C., Joaquim, H. P. G., Pedrazzi, J. F. C., Pain, A. D. O., Duque, G., & Aprahamian, I. (2022) · Brain Sciences · doi:10.3390/brainsci12121596 · Cited by 38
Chronic Stress Impairs α1-Adrenoceptor-Induced Endocannabinoid-Dependent Synaptic Plasticity in the Dorsal Raphe Nucleus
Haj‐Dahmane, S., & Shen, R. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1310-14.2014 · Cited by 38
Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice
Peñasco, S., Rico-Barrio, I., Puente, N., Fontaine, C. J., Ramos, A., Reguero, L., Gerrikagoitia, I., de Fonseca, F. R., Suarez, J., Barrondo, S., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0530-5 · Cited by 37
Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain
Morgan, A., Kingsley, P. J., Mitchener, M. M., Altemus, M., Patrick, T. A., Gaulden, A. D., Marnett, L. J., & Patel, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00499 · Cited by 37
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
Pryce, G., Cabranes, A., Fernández‐Ruíz, J., Bisogno, T., Marzo, V. D., Long, J. Z., Cravatt, B., Giovannoni, G., & Baker, D. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513485982 · Cited by 37
Sterol Carrier Protein-2: Binding Protein for Endocannabinoids
Liedhegner, E. S., Vogt, C. D., Sem, D. S., Cunningham, C. W., & Hillard, C. J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8651-7 · Cited by 37
Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT
Rempel, B. P., Price, E. W., & Phenix, C. P. (2017) · Molecular Imaging · doi:10.1177/1536012117717852 · Cited by 36
Endocannabinoid-LTP Mediated by CB1 and TRPV1 Receptors Encodes for Limited Occurrences of Coincident Activity in Neocortex
Cui, Y., Siaume‐Perez, S., & Venance, L. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00182 · Cited by 36

Authors: Katona, I., & Freund, T. F.
Affiliations: HUN-REN Institute of Experimental Medicine (HU)
ORCID: Katona, István
Freund, Tamás F.
Venue: Annual Review of Neuroscience
Publisher: Annual Reviews
Published: 2012-07-21
Volume: 35
Issue: 1
Pages: 529-558
ISSN: 0147-006X (ISSN-L)
1545-4126
DOI: 10.1146/annurev-neuro-062111-150420
PMC: PMC4273654
OpenAlex: W2168499817
Cited by: 630
References: 183
Citations by year: 2026: 39 · 2025: 35 · 2024: 29 · 2023: 44 · 2022: 53 · 2021: 60 · 2020: 56 · 2019: 32 · 2018: 50 · 2017: 57 · 2016: 34 · 2015: 45 · 2014: 43 · 2013: 41 · 2012: 11
FWCI: 5.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Annual Review of Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust (090946)
National Institute of Mental Health (R01MH054671, MH54671)
National Institute of Neurological Disorders and Stroke (R37NS030549, R01NS030549, NS30549)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords: endocannabinoid signaling, anandamide, 2-arachidonoylglycerol, signalosome, synaptic plasticity, intracellular signaling, cell type-specific signaling, brain
MeSH terms: Animals, Arachidonic Acids, Behavior, Animal, Brain, Glycerides, Humans, Ligands, Models, Neurological, Synaptic Transmission, Neuronal Plasticity, Signal Transduction, Receptors, Cannabinoid, Polyunsaturated Alkamides, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple Functions of Endocannabinoid Signaling in the Brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks